I
568.08
-5.40 (-0.94%)
Previous Close | 573.48 |
Open | 566.60 |
Volume | 748,828 |
Avg. Volume (3M) | 1,485,088 |
Market Cap | 202,338,172,928 |
Price / Earnings (TTM) | 88.49 |
Price / Earnings (Forward) | 75.19 |
Price / Sales | 25.31 |
Price / Book | 12.59 |
52 Weeks Range | |
Earnings Date | 16 Apr 2025 - 21 Apr 2025 |
Profit Margin | 28.51% |
Operating Margin (TTM) | 28.33% |
Diluted EPS (TTM) | 6.42 |
Quarterly Revenue Growth (YOY) | 16.90% |
Quarterly Earnings Growth (YOY) | 35.90% |
Total Debt/Equity (MRQ) | 1.91% |
Current Ratio (MRQ) | 4.30 |
Operating Cash Flow (TTM) | 1.82 B |
Levered Free Cash Flow (TTM) | 637.52 M |
Return on Assets (TTM) | 7.95% |
Return on Equity (TTM) | 15.97% |
Market Trend
Short Term | Medium Term | ||
Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
Medical Instruments & Supplies (Global) | Mixed | Mixed | |
Stock | Intuitive Surgical, Inc. | Bullish | Bullish |
AIStockmoo Score
1.3
Analyst Consensus | 1.5 |
Insider Activity | -3.5 |
Price Volatility | -0.5 |
Technical Moving Averages | 5.0 |
Technical Oscillators | 4.0 |
Average | 1.30 |
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 8,600 da Vinci systems in hospitals worldwide, with more than 5,000 installations in the US and a growing number in emerging markets. |
|
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Investment Style | Large Growth |
% Held by Insiders | 0.52% |
% Held by Institutions | 89.30% |
52 Weeks Range | ||
Price Target Range | ||
High | 711.00 (Citigroup, 25.16%) | Buy |
Median | 670.00 (17.94%) | |
Low | 561.00 (BTIG, -1.25%) | Buy |
Average | 657.56 (15.75%) | |
Total | 9 Buy | |
Avg. Price @ Call | 570.77 |
Firm | Date | Target Price | Call | Price @ Call |
---|---|---|---|---|
Citigroup | 24 Jan 2025 | 711.00 (25.16%) | Buy | 584.05 |
11 Dec 2024 | 640.00 (12.66%) | Buy | 543.60 | |
JP Morgan | 24 Jan 2025 | 675.00 (18.82%) | Buy | 584.05 |
Piper Sandler | 24 Jan 2025 | 670.00 (17.94%) | Buy | 584.05 |
Raymond James | 24 Jan 2025 | 688.00 (21.11%) | Buy | 584.05 |
Truist Securities | 24 Jan 2025 | 666.00 (17.24%) | Buy | 584.05 |
18 Dec 2024 | 640.00 (12.66%) | Buy | 526.47 | |
Wells Fargo | 24 Jan 2025 | 687.00 (20.93%) | Buy | 584.05 |
11 Dec 2024 | 630.00 (10.90%) | Buy | 543.60 | |
Stifel | 05 Dec 2024 | 610.00 (7.38%) | Buy | 547.65 |
Morgan Stanley | 02 Dec 2024 | 650.00 (14.42%) | Buy | 542.85 |
BTIG | 26 Nov 2024 | 561.00 (-1.25%) | Buy | 542.10 |
Show more |
Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
---|---|---|---|---|
BROSIUS MARK | - | 595.70 | -430 | -256,151 |
CHARLTON HENRY L | - | 595.70 | -492 | -293,084 |
CURET MYRIAM | - | 593.68 | -838 | -497,544 |
DESANTIS ROBERT | - | 595.70 | -388 | -231,132 |
GUTHART GARY S | - | 595.70 | -1,055 | -628,464 |
LOEB GARY | - | 592.66 | -2,769 | -1,633,659 |
MILLER BRIAN EDWARD | - | 595.70 | -669 | -398,523 |
ROSA DAVID J. | - | 595.70 | -723 | -430,691 |
SAMATH JAMIE | - | 595.70 | -750 | -446,775 |
WIDMAN FREDRIK | - | 595.70 | -298 | -177,519 |
Aggregate Net Quantity | -8,412 | |||
Aggregate Net Value ($) | -4,993,542 | |||
Aggregate Avg. Buy ($) | - | |||
Aggregate Avg. Sell ($) | 594.92 |
Name | Holder | Date | Type | Quantity | Price | Value ($) |
---|---|---|---|---|---|---|
LOEB GARY | Officer | 12 Feb 2025 | Automatic sell (-) | 2,600 | 589.61 | 1,532,986 |
LOEB GARY | Officer | 12 Feb 2025 | Option execute | 2,600 | - | - |
CURET MYRIAM | Officer | 11 Feb 2025 | Automatic sell (-) | 408 | 591.65 | 241,393 |
BROSIUS MARK | Officer | 10 Feb 2025 | Disposed (-) | 430 | 595.70 | 256,151 |
BROSIUS MARK | Officer | 10 Feb 2025 | Option execute | 838 | - | - |
CHARLTON HENRY L | Officer | 10 Feb 2025 | Disposed (-) | 492 | 595.70 | 293,084 |
CHARLTON HENRY L | Officer | 10 Feb 2025 | Option execute | 1,078 | - | - |
WIDMAN FREDRIK | Officer | 10 Feb 2025 | Disposed (-) | 298 | 595.70 | 177,519 |
WIDMAN FREDRIK | Officer | 10 Feb 2025 | Option execute | 568 | - | - |
LOEB GARY | Officer | 10 Feb 2025 | Disposed (-) | 169 | 595.70 | 100,673 |
LOEB GARY | Officer | 10 Feb 2025 | Option execute | 315 | - | - |
ROSA DAVID J. | Officer | 10 Feb 2025 | Disposed (-) | 723 | 595.70 | 430,691 |
ROSA DAVID J. | Officer | 10 Feb 2025 | Option execute | 1,437 | - | - |
DESANTIS ROBERT | Officer | 10 Feb 2025 | Disposed (-) | 388 | 595.70 | 231,132 |
DESANTIS ROBERT | Officer | 10 Feb 2025 | Option execute | 958 | - | - |
MILLER BRIAN EDWARD | Officer | 10 Feb 2025 | Disposed (-) | 669 | 595.70 | 398,523 |
MILLER BRIAN EDWARD | Officer | 10 Feb 2025 | Option execute | 1,317 | - | - |
SAMATH JAMIE | Officer | 10 Feb 2025 | Disposed (-) | 481 | 595.70 | 286,532 |
SAMATH JAMIE | Officer | 10 Feb 2025 | Automatic sell (-) | 269 | 595.70 | 160,243 |
SAMATH JAMIE | Officer | 10 Feb 2025 | Option execute | 1,347 | - | - |
GUTHART GARY S | Officer | 10 Feb 2025 | Disposed (-) | 1,055 | 595.70 | 628,464 |
GUTHART GARY S | Officer | 10 Feb 2025 | Option execute | 2,634 | - | - |
CURET MYRIAM | Officer | 10 Feb 2025 | Disposed (-) | 430 | 595.70 | 256,151 |
CURET MYRIAM | Officer | 10 Feb 2025 | Option execute | 838 | - | - |
Show more |
Date | Type | Details |
---|---|---|
03 Feb 2025 | CNBC | Trump tariffs could raise medication costs and exacerbate shortages, drug trade groups warn |
27 Jan 2025 | Announcement | Intuitive Announces $45 Million Donation to the Intuitive Foundation to Promote Health and Advance Education |
23 Jan 2025 | Announcement | Intuitive Announces Fourth Quarter Earnings |
21 Jan 2025 | Announcement | Intuitive Announces Plans to Establish Direct Presence in Italy, Spain, Portugal |
15 Jan 2025 | Announcement | Intuitive Announces Preliminary Fourth Quarter and Full Year 2024 Results |
03 Jan 2025 | Announcement | Intuitive Announces Executive Leadership Changes to Support Continued Global Growth |
05 Dec 2024 | Announcement | Meta-analysis published in Annals of Surgery shows benefits of da Vinci surgery across seven oncologic procedures compared to laparoscopic and open |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
Realized Profit | - |
Unrealized Profit | - |
Dividend Received 2025 | - |
Total Profit | - |
Avg. Return | - |
Quantity (Buy) | - |
Avg. Price (Buy) | - |
Quantity (Sold) | - |
Avg. Price (Sold) | - |